India Computed Tomography Market Size

India Computed Tomography (CT) Market Analysis

The India Computed Tomography Market size is expected to grow from USD 265.36 million in 2023 to USD 373.93 million by 2028, at a CAGR of 7.10% during the forecast period.

The COVID-19 pandemic had an impact on the Indian computed tomography market initially, with the decrease in the volume of diagnostic imaging such as computed tomography due to the massive influx of COVID-19 patients, lockdowns, and restrictions on non-urgent diagnostic procedures in hospitals. For instance, according to a study published in the Indian Journal of Radiology and Imaging in January 2021, radiology practices witnessed a significant over 60%-70% decline in imaging volumes amid the pandemic. Although, during the pandemic, the importance of chest computed tomography (CT) scans for COVID-19 patients increased, which boosted the demand for CT systems in India. Moreover, in the post-pandemic period, the number of COVID-19 patients decreased in India, which led to the resumption of the CT imaging of non-COVID and non-urgent medical cases. Thus, the pandemic had a slight negative impact on the Indian computed tomography market initially. However, the resumption of CT imaging diagnosis for other diseases enabled the need to grow generally in India.

The country has an increasing burden of chronic diseases and expanding geriatric population, which are expected to create a higher demand for CT systems for the diagnosis of highly prevalent chronic diseases such as tuberculosis, cancer, human immunodeficiency viruses (HIV), and other. For instance, as per the data published by the National AIDS Control Organization in 2021, the incidence of HIV was observed to be 62,967 cases 2021 in India. Further, the data published by the TB Facts Org in 2021, over 2.59 million new cases of HIV and tuberculosis were observed in 2021 in India. Also, as per the study published by the Indian Journal of Medical Research in 2022, the estimated number of incident cancer cases in India was found to be 1.46 million in 2022 in India. The same source further stated that one in nine people is expected to develop cancer in their lifetime, and lung and breast cancers were the leading cancer sites in males and females, respectively. With the increasing prevalence of tuberculosis, HIV, cancer, and other diseases, the patient base for these chronic diseases is expected to expand, which is likely to drive the high demand for CT imaging diagnosis and boost the market growth in the coming years.

Also, the technological advancements in computed tomography of imaging intelligence and high accuracy are expected to tap more patients in the county with its advanced features and improvisations. For instance, in April 2022, Wipro GE Healthcare launched its next-generation Revolution Aspire CT (Computed Tomography) scanner in India, the made-in-India CT scanner. The CT scanner is an advanced imaging solution with higher imaging intelligence and increased operational efficiency with up to 50% higher throughput. With the launching of such advanced and efficient CT systems, the availability of CT devices will increase in the country, tapping the unmet needs of the patient base in India and boosting market growth in the coming years.

Furthermore, the increasing investment into the healthcare infrastructure will also propel the market's growth as it will enable healthcare facilities to adopt more CT systems to meet the demand of the patients. For instance, in August 2022, the prime minister of India inaugurated a 300-bed Homi Bhabha Cancer Hospital and Research Centre at Mullanpur in Punjab, India. Further, in April 2022, South Asia's largest cancer care network was launched in Assam with the inauguration of seven hospitals dedicated to treating the disease in Assam. Also, per the data published by the Finance Ministry of India, over INR 86,606 crore (USD 105.05 million) was allocated for healthcare expenditure in the Union Budget 2022-2023. This showed an increase of 16%, compared to the allocated budget of INR 74,602 crore (USD 90.49 million) in the financial year of 2021-2022.

Therefore, with the rising burden of chronic diseases, technological advancements in computed tomography, and increasing investment in healthcare infrastructure, the studied market is anticipated to grow over the analysis period. However, the high cost associated with CT scan devices and procedures will likely impede market growth.